Henry Schein To Present At Four Investor Conferences In May
Henry Schein To Present At Four Investor Conferences In May |
[25-April-2018] |
MELVILLE, N.Y., April 25, 2018 /PRNewswire/ -- Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, announced today that the Company will present at four investor conferences in May:
Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com, clicking on "Investor Relations," and following the link for "Webcasts." Replays will be available on the Henry Schein website following the presentations. About Henry Schein, Inc. A Fortune 500® Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein's network of trusted advisors provides health care professionals with the valued solutions they need to improve operational success and clinical outcomes. The Company offers customers exclusive, innovative products and solutions, including practice management software, e-commerce solutions, specialty and surgical products, as well as a broad range of financial services. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 34 countries. The Company's sales reached a record $12.5 billion in 2017, and have grown at a compound annual rate of approximately 15 percent since Henry Schein became a public company in 1995. For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.
View original content:http://www.prnewswire.com/news-releases/henry-schein-to-present-at-four-investor-conferences-in-may-300635980.html SOURCE Henry Schein, Inc. | ||
Company Codes: NASDAQ-NMS:HSIC |
© 2018 PR Newswire. All Rights Reserved.